Skip to main content
Top
Published in: Rheumatology International 6/2013

01-06-2013 | Original Article

The prevalence of hyperuricemia and its correlates in an inland Chinese adult population, urban and rural of Jinan

Authors: Jianmin Yang, Zhendong Liu, Cheng Zhang, Yingxin Zhao, Shangwen Sun, Shujian Wang, Yuxia Zhao, Yun Zhang, Jifu Li, Fanghong Lu

Published in: Rheumatology International | Issue 6/2013

Login to get access

Abstract

Economy has developed rapidly in China, and the clustering of cardiovascular risk factors in subjects increased remarkably over the past two decades. However, no data are available regarding the temporal prevalence of hyperuricemia and its correlates in this rapidly developing area, especially in the inland area. The cross-sectional survey was based on a random sample of 4,218 residents aged 35–64 years in the Jinan area. Hyperuricemia was defined as serum uric acid ≥416 μmol/L in men and ≥357 μmol/L in women. Subjects underwent physical examination and fasting blood testing. Complete data were available for analysis from 1,979 men and 2,062 women. The age-adjusted prevalence of hyperuricemia was 6.4 % for men and 2.1 % for women. The prevalence of hyperuricemia was greater in urban (6.7 %) than in rural areas (1.7 %) of Jinan city. Multivariate logistic regression models revealed hyperuricemia associated with hypertriglyceridemia [men: odds ratio (OR) = 6.101, 95 % confidence interval (CI) 4.064–9.159; women: OR = 7.103, 95 % CI 3.578–14.099] and high serum creatinine level (men: OR = 2.603, 95 % CI 1.602–4.230; women: OR = 5.237, 95 % CI 2.667–10.284). Hyperuricemia was also significantly associated with male sex, urban residence, hypertension, obesity, and hypercholesterolemia. Age (1-year increase) was negatively associated with hyperuricemia in men but positively associated with hyperuricemia in women. In conclusion, the prevalence of hyperuricemia is higher in urban than rural areas of Jinan, China. Male sex, urban residence, hypertension, obesity, hypercholesterolemia, hypertriglyceridemia, and high serum creatinine level contributed to hyperuricemia in this population.
Literature
1.
go back to reference Bulpitt CJ (1975) Serum uric acid in hypertensive patients. Br Heart J 37:1210–1215CrossRef Bulpitt CJ (1975) Serum uric acid in hypertensive patients. Br Heart J 37:1210–1215CrossRef
2.
go back to reference World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organization technical report series 854, pp 1–452 World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organization technical report series 854, pp 1–452
3.
go back to reference Chelchowska M, Ambroszkiewicz J, Gajewska J, Laskowska-Klita T, Leibschang J (2007) The effect of tobacco smoking during pregnancy on concentration of uric acid in matched-maternal cord pairs. Przegl Lek 64:667–670PubMed Chelchowska M, Ambroszkiewicz J, Gajewska J, Laskowska-Klita T, Leibschang J (2007) The effect of tobacco smoking during pregnancy on concentration of uric acid in matched-maternal cord pairs. Przegl Lek 64:667–670PubMed
4.
go back to reference Chen S, Du H, Wang Y, Xu L (1998) The epidemiology study of hyperuricemia and gout in a community population of Huangpu District in Shanghai. Chin Med J 111:228–230PubMed Chen S, Du H, Wang Y, Xu L (1998) The epidemiology study of hyperuricemia and gout in a community population of Huangpu District in Shanghai. Chin Med J 111:228–230PubMed
5.
go back to reference Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363:1277–1281CrossRef Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363:1277–1281CrossRef
6.
go back to reference Choi HK, Liu S, Curhan G (2005) Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthr Rheum 52:283–289CrossRef Choi HK, Liu S, Curhan G (2005) Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthr Rheum 52:283–289CrossRef
7.
go back to reference Chu NF, Wang DJ, Liou SH, Shieh SM (2000) Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan. Eur J Epidemiol 16:13–17CrossRef Chu NF, Wang DJ, Liou SH, Shieh SM (2000) Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan. Eur J Epidemiol 16:13–17CrossRef
8.
go back to reference Chungtei C (2003) Hyperuricemia and gout among Taiwan Aborigines and Taiwanese-prevalence and risk factors. Chin Med J 116:965–967PubMed Chungtei C (2003) Hyperuricemia and gout among Taiwan Aborigines and Taiwanese-prevalence and risk factors. Chin Med J 116:965–967PubMed
9.
go back to reference Conen D, Wietlisbach V, Bovet P et al (2004) Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 4:9CrossRef Conen D, Wietlisbach V, Bovet P et al (2004) Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 4:9CrossRef
10.
go back to reference Cuspidi C, Valerio C, Sala C et al (2007) Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Am J Hypertens J Am Soc Hypertens 20:678–685CrossRef Cuspidi C, Valerio C, Sala C et al (2007) Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Am J Hypertens J Am Soc Hypertens 20:678–685CrossRef
11.
go back to reference Daudon M, Traxer O, Conort P, Lacour B, Jungers P (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol JASN 17:2026–2033CrossRef Daudon M, Traxer O, Conort P, Lacour B, Jungers P (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol JASN 17:2026–2033CrossRef
12.
go back to reference Ebrahimpour P, Fakhrzadeh H, Heshmat R, Bandarian F, Larijani B (2008) Serum uric acid levels and risk of metabolic syndrome in healthy adults. Endocr Practice Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 14:298–304 Ebrahimpour P, Fakhrzadeh H, Heshmat R, Bandarian F, Larijani B (2008) Serum uric acid levels and risk of metabolic syndrome in healthy adults. Endocr Practice Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 14:298–304
13.
go back to reference Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA, J Am Med Assoc 283:2404–2410CrossRef Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA, J Am Med Assoc 283:2404–2410CrossRef
14.
go back to reference Feig DI, Johnson RJ (2003) Hyperuricemia in childhood primary hypertension. Hypertension 42:247–252CrossRef Feig DI, Johnson RJ (2003) Hyperuricemia in childhood primary hypertension. Hypertension 42:247–252CrossRef
15.
go back to reference Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. New Engl J Med 359:1811–1821CrossRef Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. New Engl J Med 359:1811–1821CrossRef
16.
go back to reference Ferns GA, Lanham J, Dieppe P, Galton DJ (1988) A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridaemia of primary gout. Hum Genet 78:55–59CrossRef Ferns GA, Lanham J, Dieppe P, Galton DJ (1988) A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridaemia of primary gout. Hum Genet 78:55–59CrossRef
17.
go back to reference Fuchs FD, Chambless LE, Whelton PK, Nieto FJ, Heiss G (2001) Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities Study. Hypertension 37:1242–1250CrossRef Fuchs FD, Chambless LE, Whelton PK, Nieto FJ, Heiss G (2001) Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities Study. Hypertension 37:1242–1250CrossRef
18.
go back to reference Gotoh M, Li C, Yatoh M, Iguchi A, Hirooka Y (2005) Serum uric acid concentrations in type 2 diabetes: its significant relationship to serum 1,5-anhydroglucitol concentrations. Endocr Regul 39:119–125PubMed Gotoh M, Li C, Yatoh M, Iguchi A, Hirooka Y (2005) Serum uric acid concentrations in type 2 diabetes: its significant relationship to serum 1,5-anhydroglucitol concentrations. Endocr Regul 39:119–125PubMed
19.
go back to reference Hakoda M (2008) Epidemiology of hyperuricemia and gout in Japan. Nippon rinsho. Jpn J Clin Med 66:647–652 Hakoda M (2008) Epidemiology of hyperuricemia and gout in Japan. Nippon rinsho. Jpn J Clin Med 66:647–652
20.
go back to reference He J, Gu D, Wu X et al (2005) Major causes of death among men and women in China. New Engl J Med 353:1124–1134CrossRef He J, Gu D, Wu X et al (2005) Major causes of death among men and women in China. New Engl J Med 353:1124–1134CrossRef
21.
go back to reference Jackson L, Taylor R, Faaiuso S, Ainuu SP, Whitehouse S, Zimmet P (1981) Hyperuricaemia and gout in Western Samoans. J Chronic Dis 34:65–75CrossRef Jackson L, Taylor R, Faaiuso S, Ainuu SP, Whitehouse S, Zimmet P (1981) Hyperuricaemia and gout in Western Samoans. J Chronic Dis 34:65–75CrossRef
22.
go back to reference Ko YC, Huang MC, Wang TN, Chang SJ, Tsai LY, Tu HP (2005) Prevalence and risk factors associated with dyslipidaemia in children and adolescents among ethnic groups in Taiwan. Public Health 119:489–497CrossRef Ko YC, Huang MC, Wang TN, Chang SJ, Tsai LY, Tu HP (2005) Prevalence and risk factors associated with dyslipidaemia in children and adolescents among ethnic groups in Taiwan. Public Health 119:489–497CrossRef
23.
go back to reference Kosugi T, Nakagawa T, Kamath D, Johnson RJ (2009) Uric acid and hypertension: an age-related relationship. J Hum Hypertens 23:75–76CrossRef Kosugi T, Nakagawa T, Kamath D, Johnson RJ (2009) Uric acid and hypertension: an age-related relationship. J Hum Hypertens 23:75–76CrossRef
24.
go back to reference Langlois M, De Bacquer D, Duprez D, De Buyzere M, Delanghe J, Blaton V (2003) Serum uric acid in hypertensive patients with and without peripheral arterial disease. Atherosclerosis 168:163–168CrossRef Langlois M, De Bacquer D, Duprez D, De Buyzere M, Delanghe J, Blaton V (2003) Serum uric acid in hypertensive patients with and without peripheral arterial disease. Atherosclerosis 168:163–168CrossRef
25.
go back to reference Li D, Yu X, Zhou X, Siriamornpun S, Wahlqvist ML (2006) Uric acid status and its correlates in Hangzhou urban population. Asia Pac J Clin Nutr 15:102–106PubMed Li D, Yu X, Zhou X, Siriamornpun S, Wahlqvist ML (2006) Uric acid status and its correlates in Hangzhou urban population. Asia Pac J Clin Nutr 15:102–106PubMed
26.
go back to reference Li Y, Stamler J, Xiao Z, Folsom A, Tao S, Zhang H (1997) Serum uric acid and its correlates in Chinese adult populations, urban and rural, of Beijing. The PRC-USA Collaborative Study in Cardiovascular and Cardiopulmonary Epidemiology. Int J Epidemiol 26:288–296CrossRef Li Y, Stamler J, Xiao Z, Folsom A, Tao S, Zhang H (1997) Serum uric acid and its correlates in Chinese adult populations, urban and rural, of Beijing. The PRC-USA Collaborative Study in Cardiovascular and Cardiopulmonary Epidemiology. Int J Epidemiol 26:288–296CrossRef
27.
go back to reference Liberopoulos E, Miltiadous G, Elisaf M (2002) Hypouricaemia as a marker of a generalized proximal tubular damage in alcoholic patients. Alcohol Alcohol 37:472–474CrossRef Liberopoulos E, Miltiadous G, Elisaf M (2002) Hypouricaemia as a marker of a generalized proximal tubular damage in alcoholic patients. Alcohol Alcohol 37:472–474CrossRef
28.
go back to reference Liu CS, Li TC, Lin CC (2003) The epidemiology of hyperuricemia in children of Taiwan aborigines. J Rheumatol 30:841–845PubMed Liu CS, Li TC, Lin CC (2003) The epidemiology of hyperuricemia in children of Taiwan aborigines. J Rheumatol 30:841–845PubMed
29.
go back to reference Lu Z, Dong B, Wu H et al (2009) Serum uric acid level in primary hypertension among Chinese nonagenarians/centenarians. J Hum Hypertens 23:113–121CrossRef Lu Z, Dong B, Wu H et al (2009) Serum uric acid level in primary hypertension among Chinese nonagenarians/centenarians. J Hum Hypertens 23:113–121CrossRef
30.
go back to reference Moriwaki Y, Yamamoto T, Takahashi S, Tsutsumi Z, Higashino K (1995) Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia. Ann Rheum Dis 54:351–354CrossRef Moriwaki Y, Yamamoto T, Takahashi S, Tsutsumi Z, Higashino K (1995) Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia. Ann Rheum Dis 54:351–354CrossRef
31.
go back to reference Nakamura K, Sakurai M, Miura K et al (2012) Alcohol intake and the risk of hyperuricaemia: a 6-year prospective study in Japanese men. Nutr Metab Cardiovasc Dis NMCD 22:989–996CrossRef Nakamura K, Sakurai M, Miura K et al (2012) Alcohol intake and the risk of hyperuricaemia: a 6-year prospective study in Japanese men. Nutr Metab Cardiovasc Dis NMCD 22:989–996CrossRef
32.
go back to reference Nan H, Qiao Q, Dong Y et al (2006) The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 33:1346–1350PubMed Nan H, Qiao Q, Dong Y et al (2006) The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 33:1346–1350PubMed
33.
go back to reference Ong KL, Cheung BM, Man YB, Lau CP, Lam KS (2007) Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension 49:69–75CrossRef Ong KL, Cheung BM, Man YB, Lau CP, Lam KS (2007) Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension 49:69–75CrossRef
34.
go back to reference Reilly KH, Gu D, Duan X et al (2008) Risk factors for chronic obstructive pulmonary disease mortality in Chinese adults. Am J Epidemiol 167:998–1004CrossRef Reilly KH, Gu D, Duan X et al (2008) Risk factors for chronic obstructive pulmonary disease mortality in Chinese adults. Am J Epidemiol 167:998–1004CrossRef
35.
go back to reference Slater PE, Kaufmann NA, Friedlander Y, Stein Y (1985) Effects of smoking and physical activity on serum uric acid in a Jerusalem population sample. Ann Hum Biol 12:179–184CrossRef Slater PE, Kaufmann NA, Friedlander Y, Stein Y (1985) Effects of smoking and physical activity on serum uric acid in a Jerusalem population sample. Ann Hum Biol 12:179–184CrossRef
36.
go back to reference Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R (2004) Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 31:1582–1587PubMed Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R (2004) Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 31:1582–1587PubMed
37.
go back to reference Yue JR, Huang CQ, Dong BR (2012) Association of serum uric acid with body mass index among long-lived Chinese. Exp Gerontol (Epub ahead of print) Yue JR, Huang CQ, Dong BR (2012) Association of serum uric acid with body mass index among long-lived Chinese. Exp Gerontol (Epub ahead of print)
Metadata
Title
The prevalence of hyperuricemia and its correlates in an inland Chinese adult population, urban and rural of Jinan
Authors
Jianmin Yang
Zhendong Liu
Cheng Zhang
Yingxin Zhao
Shangwen Sun
Shujian Wang
Yuxia Zhao
Yun Zhang
Jifu Li
Fanghong Lu
Publication date
01-06-2013
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 6/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2589-8

Other articles of this Issue 6/2013

Rheumatology International 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine